[Webinar] Data Driven Enforcement – Risks of Open Payments and Medicare Part D Data

0 1,678

On Monday, November 14th, 2016, qordata is hosting a webinar on the topic, ‘Data Driven Enforcement – Risks of Open Payments and Medicare Part D Data’ at 11am CST. The webinar aims to provide a review of the cases against Insys Therapeutics Inc., and analyze the data that prosecutors used as part of the allegations against the manufacturer. The speakers of the webinar, Brian A. Dahl, Principal, Dahl Compliance Consulting LLC, and Mohammad Ovais, Founder & CEO, qordata, will also discuss the ways in which compliance teams can analyze publicly available Open Payments and Medicare Part D data to avoid risks of kickback violations.

The webinar hopes to provide attendees with a working knowledge of: how to analyze spend data from Open Payments and prescriptions from Medicare Part D to highlight certain high risk physicians, some key similarities in high risk physicians that compliance should be aware of and stay on top of, and information on how to reduce compliance risks within your organization. 

Agenda

The webinar will start with a review of the cases filed against Insys Therapeutics Inc., and how publicly available Open Payments and Medicare Part D was used by investigators to place allegations on the manufacturer. From there, the discussion will turn to the importance of and how manufacturers can evaluate their spend data prior to CMS submission and how high risk physicians can be identified using spend and prescription data.

Speakers

Attendees of the webinar will get to hear from Brian A. Dahl, Principal, Dahl Compliance Consulting LLC, and Mohammad Ovais, Founder & CEO, qordata.

Registration

We encourage our readers to consider attending, as Chief Compliance Officers, Directors of Compliance, Managers of Compliance, Compliance Analysts, and Compliance Specialists, among others, have the potential to greatly benefit from this webinar. If you are interested in the webinar, you can register for free HERE.

Leave A Reply

Your email address will not be published.